Compared with placebo, tirzepatide 15 mg was the most efficacious treatment in reducing HbA 1c (mean difference 21.61 mmol/mol [1.96%]) followed by tirzepatide 10 mg (20.19 mmol/mol [1.84%]), semaglutide 2.0 mg (17.74 mmol/mol [1.59%]), tirzepatide 5 mg (17.60 mmol/mol [1.60%]), semaglutide 1.0 mg (15.25 mmol/mol [1.39%]) and semaglutide 0.5 mg (12.00 mmol/mol [1.09%])
The uneven weekly rhythm can cause confusion
Some studies suggest that gastrointestinal side effects improve within four to eight weeks at each dose level
It's also important to be aware of serious conditions that require urgent evaluation regardless of medication expiration status, including severe abdominal pain radiating to the back (possible pancreatitis) or persistent right upper quadrant pain, fever, or jaundice (possible gallbladder disease)both known risks with GLP-1 receptor agonists
Include decision diamond at Phase 4 splitting into "Resolution" and "Persistent" paths.] The value of this model is prognostic
Maintain confidence with subtle, refreshed results
